Goldenwell Biotech receives legal counsel's support for Form 8-K filing.
Goldenwell Biotech's law firm, Michael Gillespie & Associates, PLLC, affirmed the company's statements in the included Form 8-K dated September 28, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed